Pacer Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Pacer Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,363	Closed	-$3.37M	–	3803
2024 Q1	$3.37M	Buy	10,363 +4,816	+87%	+$1.18M	0.01%	690
2023 Q4	$1.06M	Buy	5,547 +2,476	+81%	+$468K	﹤0.01%	1125
2023 Q3	$611K	Sell	3,071 -4,650	-60%	-$1.1M	﹤0.01%	1037
2023 Q2	$2.2M	Buy	7,721 +6,331	+455%	+$1.76M	0.01%	702
2023 Q1	$301K	Sell	1,390 -5,532	-80%	-$1.08M	﹤0.01%	1261
2022 Q4	$1.42M	Buy	6,922 +5,842	+541%	+$1.48M	0.01%	667
2022 Q3	$300K	Buy	+1,080	New	+$275K	﹤0.01%	1323

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Pacer Advisors's SWAV Position: Q2 2024 in Review

Pacer Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 10,363 shares — an estimated $3.37M sold.

Pacer Advisors first reported a position in SWAV in Q3 2022 and held it in 7 quarters. The position peaked at $3.37M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Pacer Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Pacer Advisors sold 10,363 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.37M.
Pacer Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Pacer Advisors's Shockwave Medical, Inc. Common Stock position peaked at $3.37M in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.